The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Guseva M.R.

Kafedra oftal'mologii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Khachanova N.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Issues of the current terminology in multiple sclerosis

Authors:

Boĭko A.N., Guseva M.R., Khachanova N.V., Gusev E.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2): 121‑127

DOI: 10.17116/jnevro2018118082121

Read: 10696 times

Download PDF (RU)
Contact the author
Table of contents

ISSUES OF THE CURRENT TERMINOLOGY IN MULTIPLE SCLEROSIS
ISSUES OF THE CURRENT TERMINOLOGY IN MULTIPLE SCLEROSIS

To cite this article:

Boĭko AN, Guseva MR, Khachanova NV, Gusev EI. Issues of the current terminology in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2):121‑127. (In Russ.)
https://doi.org/10.17116/jnevro2018118082121

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnostic scales for acute appe­ndicitis in children. Piro­gov Russian Journal of Surgery. 2024;(10):80-87
Cere­brolysin in the preventive therapy of deme­ntia in elde­rly patients with mild cognitive impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):51-59
The use of arti­ficial inte­lligence in modern dentistry in the Russian Fede­ration. Stomatology. 2024;(5):42-45
Unre­solved problem: Chemotherapy-Induced Peri­pheral Neuropathy. P.A. Herzen Journal of Onco­logy. 2024;(5):76-81
Quality asse­ssment of health care deli­very to patients with sexually transmitted infe­ctions in dermatovenereological institutions of Moscow acco­rding to medi­cal reco­rds analysis. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):503-509
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Low-level laser therapy in multiple scle­rosis: justification and opti­mization methods of application. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):45-56
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
An indi­vidual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102
Abstract:

New terminology used by neurologists with multiple sclerosis (MS). The current use of terms «definite» MS, «MS signs», «retrobulbar neuritis» and «optic neuritis», «relapse and exacerbation, types of MS course, criteria of effectiveness of MS therapy, NEDA, NEP, NEPAD; the classification therapy methods — «escalation», «induction» and therapy of immune reconstitution (TIR), therapy of maintenance/escalation (TME) and discussed.

Keywords:

multiple sclerosis
terminology
diagnostics
treatment

Authors:

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Guseva M.R.

Kafedra oftal'mologii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Khachanova N.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Close metadata

References:

  1. Gusev EI, Boyko AN, Stoliarov ID. Multiple sclerosis (handbook of terminology). M.: Real Time; 2009. (In Russ.)
  2. Gusev EI, Boyko AN, Stoliarov ID. Multiple sclerosis (handbook of terminology). M.: Zdorovie cheloveka; 2015. (In Russ.)
  3. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;1474-4422(17):30470-30472. https://doi.org/10.1016/S1474-4422(17)30470-2
  4. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS.Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.
  5. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the McDonald Criteria. Ann Neurol. 2005;58:840-846.
  6. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JSDiagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
  7. Schumacher GA, Beebe G, Kibler RF, Kurland RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL. Problems of experimental trials of therapy in multiple sclerosis — report by the Panel on the Evaluation of Experimental Trials of Therapy in Multiple Sclerosis. Ann NY Acad Sci. 1965;122:552-568.
  8. Boyko A, Kesselring J, Paty DW, Siva A, Singhal B, Thompson A, Willoughby E. Multiple sclerosis and public health. Educational and management implications. World Health Organization, Department of Mental Health, Neuroscience and Neurological Disorders. 1999;2:1-11.
  9. Dixon C, Robertson D. To diagnose or not to diagnose? Timing is the question: balancing early diagnosis of multiple sclerosis with misdiagnosis. Expert Rev Neurother. 2018. https://doi.org/10.1080/14737175.2018
  10. Matute-Blanch C, Montalban X, Comabella M. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system. Handb Clin Neurol. 2017;146:67-84. https://doi.org/10.1016/B978-0-12-804279-3.00005-8
  11. Baranova NS, Spirin NN, Fadeeva OA, Shipova EG, Stepanov IO. Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features. Zhurnal Nevroogii i Psikhiatrii im. S.S. Korsakova. 2012;112(2-2):64-68. (In Russ.)
  12. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidellines for research protocols. Ann Neurol. 1983;13:227-231.
  13. Dubuisson N, Puentes F, Giovannoni G, Gnanapavan S. Science is 1% inspiration and 99% biomarkers. Mult Scler. 2017;23(11):1442-1452. https://doi.org/10.1177/1352458517709362
  14. Balashov K. Imaging of Central Nervous System Demyelinating Disorders. Continuum (Minneap Minn). 2016;22(5, Neuroimaging):1613-1635.
  15. Chen JJ, Carletti F, Young V, Mckean D, Quaghebeur G. MRI differential diagnosis of suspected multiple sclerosis. Clin Radiol. 2016;71(9):815-827. https://doi.org/10.1016/j.crad.2016.05.010
  16. Bernitsas E, Khan O, Razmjou S, Tselis A, Bao F, Caon C, Millis S, Seraji-Bozorgzad N. Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis. PLoS One. 2017;12(7):e0181431. https://doi.org/10.1371/journal.pone.0181431
  17. Stangel M, Fredrikson S, Meinl E, Petzold A, Stüve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol. 2013;9(5):267-276. https://doi.org/10.1038/nrneurol.2013.41
  18. Nikiforov AS, Guseva MR. Neuroophtalmology. M.: GOETAR-media; 2008. (In Russ.)
  19. Zmurkin VP, Pak SG, Pirogov AI. The Great Medical Encyclopedia. http://бмэ.орг/index.php (In Russ.)
  20. Popova EV, Bryukhov VV, Boyko AN, Krotenkova MV, Konovalova OE, Sharanova SN. Atypical multiple sclerosis — Balo’s concentric sclerosis: two case-reports and a review. Zhurnal Nevroogii i Psikhiatrii im. S.S. Korsakova. 2017;2(2):50-53. (In Russ.) https://doi.org/10.17116/jnevro20171172250-53
  21. Purohit B, Ganewatte E, Schreiner B, Kollias S. Balo’s Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI. Case Rep Neurol. 2015;7(1):44-50. https://doi.org/10.1159/000380813
  22. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-286. https://doi.org/10.1212/WNL.0000000000000560
  23. Giovannoni G, Bermel R, Phillips T, Rudick R A brief history of NEDA. Mult Scler Relat Disord. 2018;20:228-230. https://doi.org/10.1016/j.msard.2017.07.011
  24. Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS. ORATORIO Clinical Investigators Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med. 2017;376(3):209-220. https://doi.org/10.1056/NEJMoa1606468
  25. Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L. OPERA I and OPERA II Clinical Investigators. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med. 2017;376(3):221-234. https://doi.org/10.1056/NEJMoa1601277
  26. Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Mult Scler J Exp Transl Clin. 2018;4(1):2055217318760642. https://doi.org/10.1177/2055217318760642
  27. Montalban X, Wolinsky JS, Kappos L, Hauser SL, Giovannoni G, de Seze J, Bar-Or A, Masterman D, Bernasconi C, Wei W, Garren H, Chin P, Belachew S, Arnold DL. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. Presented at the 3rd Congress of the European Academy of Neurology (EAN) 24—27 June 2017; Amsterdam: The Netherlands, Platform presentation number PR2086.
  28. Boyko AN, Gusev EI. Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient Zhurnal Nevroogii i Psikhiatrii im. S.S. Korsakova. 2017;2(2):92-106. (In Russ.) https://doi.org/10.17116/jnevro20171172292-106
  29. Criteria of noneffective and change of the first DMT to second line. Zhurnal Nevroogii i Psikhiatrii im. S.S. Korsakova. 2015;115(8-2):44. (In Russ.)
  30. Baker D, Herrod SS, Alvarez-Gonzalez C, Giovannoni G, Schmierer K. Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab. JAMA Neurol. 2017;74(8):961-969. https://doi.org/10.1001/jamaneurol.2017.0676
  31. Boyko AN, Boyko OV. Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis. Degenerative Neurological and Neuromuscular Disease. 2018;8:35-44. https://doi.org/10.2147/DNND.S161450
  32. Giovannoni G. Cladribine to Treat Relapsing Forms of Multiple Sclerosis. Neurotherapeutics. 2017;14(4):874-887. https://doi.org/10.1007/s13311-017-0573-4
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.